Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
인슐린 전달 기기 시장 규모는 예측 기간 동안 연평균 8.71%의 CAGR을 기록하며 2033년 701억 4,000만 달러 규모로 성장할 것으로 예상됩니다.
인슐린 전달 기기 시장은 COVID-19 사태로 인해 큰 영향을 받았으며, 제 1형 당뇨병 환자는 COVID-19의 영향을 더 많이 받습니다. 이미 면역 체계가 저하되어 있기 때문에 COVID-19에 노출되면 빠르게 악화됩니다. 또한 건강한 사람보다 심각한 합병증에 더 취약 할 수 있습니다.
세계 인슐린 전달 기기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 시장 역학
- 성장 촉진요인·억제·기회·과제 분석
- COVID-19에 의한 시장에 대한 영향
제5장 시장 변수와 전망
- SWOT 분석
- PESTEL 분석
- Porter's Five Forces 분석
- 히트맵 분석
제6장 경쟁 상황
- 제조 거점 분포·판매 지역·제품 유형
- M&A·제휴·제품 발매·협력
제7장 인슐린 전달 기기 시장 : 유형별
- 세계의 시장 규모 점유율·예측
- 인슐린 펜
- 인슐린 펌프
- 인슐린 주사기
- 인슐린 펜 바늘
제8장 인슐린 전달 기기 시장 : 최종사용자별
- 세계의 시장 규모 점유율·예측
- 병원·클리닉
- 환자·재택 케어
제9장 인슐린 전달 기기 시장 예측
제10장 인슐린 전달 기기 시장 : 유형별
제11장 인슐린 전달 기기 시장 : 최종사용자별
제12장 인슐린 전달 기기 시장 : 지역별
- 시장 규모·시장 점유율 추정과 예측
- 동부
- 서부
- 북부
- 남부
제13장 기업 개요
- Biocon Limited
- Diabetes Care Business
- Eli Lilly and Company
- Hindustan Syringes & Medical Devices Ltd.
- Insulet Corporation
- Mannkind Corporation
- Sanofi
- Terumo Corporation
- Vicentra B.V.
- Others
제14장 약어 리스트
제15장 참고 링크
제16장 결론
제17장 조사 범위
ksm
Insulin Delivery Devices Market Introduction and Overview
According to SPER market research, 'Insulin Delivery Devices Market Size- By Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Insulin Delivery Devices Market is predicted to reach USD 70.14 billion by 2033 with a CAGR of 8.71%.
The beta cells in the islets of Langerhans of the pancreas produce the hormone insulin. By promoting cellular glucose uptake and controlling the metabolism of fats, proteins, and carbohydrates, the hormone keeps blood glucose levels within normal ranges. Type I and type II diabetes can be brought on by inappropriate insulin function brought on by damaged beta cells or the body's incapacity to utilize the insulin that is produced.
Furthermore, the market for insulin delivery devices was significantly impacted by the COVID-19 pandemic. Patients with type 1 diabetes are more affected by COVID-19. Due to their already compromised immune systems, people with diabetes quickly deteriorate when exposed to COVID-19. Individuals with diabetes may be more susceptible than healthy individuals to major complications.
Scope of the Report:
Report Metric Details
Market size available for years 2019-2033
Base year considered 2022
Forecast period 2023-2033
Segments covered By Type, By End User.
Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered Biocon Limited, Eli Lilly and Company, Hindustan Syringes & Medical Devices Ltd, Insulet Corporation, Mannkind Corporation, Medtronic, Sanofi, Terumo Corporation, and Vicentra B.V.
Insulin Delivery Devices Market Segmentation:
By Type: Based on the Method type, Insulin Delivery Devices Market is segmented as; Insulin Pens (Reusable, Disposable), Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standards & Safety).
By End User: Based on the End User, Insulin Delivery Devices Market is segmented as; (Hospitals & Clinics, Patients & Homecare).
By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
Table of Contents
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 4.2. COVID-19 Impacts of the Insulin Delivery Devices Market
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Insulin Delivery Devices Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Insulin Delivery Devices Market
7. Insulin Delivery Devices Market, By Type (USD Million)
- 7.1. Insulin Delivery Devices Market Value Share and Forecast, By Type, 2023-2033
- 7.2. Insulin Pens
- 7.3. Insulins Pumps
- 7.4. Insulin Syringes
- 7.5. Insulin Pen Needles
8. Insulin Delivery Devices Market, By End User (USD Million)
- 8.1. Insulin Delivery Devices Market Value Share and Forecast, By Vehicle type, 2023-2033
- 8.2. Hospitals & Clinics
- 8.3. Patients & Homecare
9. Insulin Delivery Devices Market Forecast, 2019-2033 (USD Million)
- 9.1. Insulin Delivery Devices Market Size and Market Share
10. Insulin Delivery Devices Market, By Type, 2019-2033 (USD Million)
- 10.1. Insulin Delivery Devices Market Size and Market Share By Type (2019-2026)
- 10.2. Insulin Delivery Devices Market Size and Market Share By Type (2027-2033)
11. Insulin Delivery Devices Market, By End User, 2019-2033 (USD Million)
- 11.1. Insulin Delivery Devices Market Size and Market Share By End User (2019-2026)
- 11.2. Insulin Delivery Devices Market Size and Market Share By End User (2027-2033)
12. Insulin Delivery Devices Market, By Region, 2019-2033 (USD Million)
- 12.1. Insulin Delivery Devices Market Size and Market Share By Region (2019-2026)
- 12.2. Insulin Delivery Devices Market Size and Market Share By Region (2027-2033)
- 12.3. Eastern Region
- 12.4. Western Region
- 12.5. Northern Region
- 12.6. Southern Region
13. Company Profile
- 13.1. Biocon Limited
- 13.1.1. Company details
- 13.1.2. Financial outlook
- 13.1.3. Product summary
- 13.1.4. Recent developments
- 13.2. Diabetes Care Business
- 13.2.1. Company details
- 13.2.2. Financial outlook
- 13.2.3. Product summary
- 13.2.4. Recent developments
- 13.3. Eli Lilly and Company
- 13.3.1. Company details
- 13.3.2. Financial outlook
- 13.3.3. Product summary
- 13.3.4. Recent developments
- 13.4. Hindustan Syringes & Medical Devices Ltd.
- 13.4.1. Company details
- 13.4.2. Financial outlook
- 13.4.3. Product summary
- 13.4.4. Recent developments
- 13.5. Insulet Corporation
- 13.5.1. Company details
- 13.5.2. Financial outlook
- 13.5.3. Product summary
- 13.5.4. Recent developments
- 13.6. Mannkind Corporation
- 13.6.1. Company details
- 13.6.2. Financial outlook
- 13.6.3. Product summary
- 13.6.4. Recent developments
- 13.7. Sanofi
- 13.7.1. Company details
- 13.7.2. Financial outlook
- 13.7.3. Product summary
- 13.7.4. Recent developments
- 13.8. Terumo Corporation
- 13.8.1. Company details
- 13.8.2. Financial outlook
- 13.8.3. Product summary
- 13.8.4. Recent developments
- 13.9. Vicentra B.V.
- 13.9.1. Company details
- 13.9.2. Financial outlook
- 13.9.3. Product summary
- 13.9.4. Recent developments
- 13.10. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
